NCT02347254View on ClinicalTrials.gov

ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease

NAActive, not recruitingINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Parkinson's Disease

Interventions

DEVICE

Transcranial ExAblate

Transcranial ExAblate MRgFUS

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors

lead

InSightec

INDUSTRY